Q4 2021 DURECT Corp Earnings Call Transcript
Greetings and welcome to the DURECT Corporation Fourth Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. (Operator Instructions) Please note that this conference is being recorded.
I will now turn the conference over to our host, Mike Arenberg, Chief Financial Officer. Thank you, sir. You may begin.
Good afternoon and welcome to our fourth quarter 2021 earnings conference call. This is Mike Arenberg, Chief Financial Officer of DURECT Corporation.
Before beginning, I would like to remind you our safe harbor statement. During the course of this call, we may make forward-looking statements regarding DURECT's products and development, expected product benefits, our development plans, future clinical trials or projected financial results.
These forward-looking statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. Further information
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |